We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
+20.87%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$38.4B
AUM Growth
+$3.99B
(+12%)
Cap. Flow
-$1.06B
Cap. Flow
% of AUM
-2.76%
Top 10 Holdings %
Top 10 Hldgs %
28.98%
Holding
520
New
61
Increased
186
Reduced
165
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$202M |
| 2 |
Qualcomm
QCOM
|
+$182M |
| 3 |
DraftKings
DKNG
|
+$177M |
| 4 |
Advanced Micro Devices
AMD
|
+$160M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$530M |
| 2 |
Boston Scientific
BSX
|
+$341M |
| 3 |
Fidelity National Information Services
FIS
|
+$299M |
| 4 |
Crown Castle
CCI
|
+$214M |
| 5 |
Intercontinental Exchange
ICE
|
+$206M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.81% |
| 2 | Healthcare | 20.96% |
| 3 | Consumer Discretionary | 14.53% |
| 4 | Communication Services | 9.02% |
| 5 | Financials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Fate Therapeutics
FATE
$286M
| $1.35M | ﹤0.01% |
14,837
-13,326
| -47% | -$828K |
|
352
Lamar Advertising Co
LAMR
$16.2B
| $1.33M | ﹤0.01% |
16,046
| – | – |
|
|
CNST
353
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $1.32M | ﹤0.01% |
45,811
-32,373
| -41% | -$815K |
|
354
Welltower
WELL
$169B
| $1.29M | ﹤0.01% |
19,904
| – | – |
|
355
New Oriental
EDU
$9.37B
| $1.21M | ﹤0.01% |
6,500
-2,700
| -29% | -$454K |
|
356
TotalEnergies
TTE
$195B
| $1.21M | ﹤0.01% |
28,832
+8,942
| +45% | +$345K |
|
357
Axsome Therapeutics
AXSM
$11.2B
| $1.2M | ﹤0.01% |
14,670
-331
| -2% | -$24.8K |
|
358
Novartis
NVS
$297B
| $1.19M | ﹤0.01% |
12,635
-13,067
| -51% | -$1.14M |
|
|
GRMN
359
Garmin
GRMN
$56.7B
| $1.17M | ﹤0.01% |
9,799
| – | – |
|
360
iShares Russell 2000 Growth ETF
IWO
$14.3B
| $1.15M | ﹤0.01% |
4,016
+3,202
| +393% | +$816K |
|
361
Equinix
EQIX
$101B
| $1.12M | ﹤0.01% |
1,568
+1
| +0.1% | +$744 |
|
362
StoneCo
STNE
$2.77B
| $1.12M | ﹤0.01% |
13,294
-7,206
| -35% | -$483K |
|
363
Carlyle Group
CG
$16.6B
| $1.11M | ﹤0.01% |
35,417
| – | – |
|
|
ONC
364
BeOne Medicines Ltd
ONC
$32.8B
| $1.11M | ﹤0.01% |
4,293
-97
| -2% | -$26.7K |
|
365
Americold
COLD
$4.02B
| $1.09M | ﹤0.01% |
29,131
| – | – |
|
366
GSK
GSK
$104B
| $1.08M | ﹤0.01% |
23,466
| – | – |
|
|
CONE
367
DELISTED
CyrusOne Inc Common Stock
CONE
| $1.08M | ﹤0.01% |
14,754
| – | – |
|
368
Sempra
SRE
$57.9B
| $1.03M | ﹤0.01% |
16,180
+6
| +0% | +$386 |
|
369
BioLife Solutions
BLFS
$1.53B
| $1M | ﹤0.01% |
+25,146
| New | +$857K |
|
|
RETA
370
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $992K | ﹤0.01% |
8,028
-181
| -2% | -$23.8K |
|
371
Biogen
BIIB
$30B
| $969K | ﹤0.01% |
3,959
+3,942
| +23,188% | +$1.02M |
|
372
Johnson Controls International
JCI
$88.8B
| $967K | ﹤0.01% |
20,761
| – | – |
|
373
General Dynamics
GD
$104B
| $936K | ﹤0.01% |
6,290
| – | – |
|
374
Cheniere Energy
CQP
$31.9B
| $931K | ﹤0.01% |
26,416
| – | – |
|
|
XLRN
375
DELISTED
Acceleron Pharma
XLRN
| $907K | ﹤0.01% |
7,091
-160
| -2% | -$18.8K |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q4 2020 Portfolio in Review
As of Q4 2020, Fred Alger Management held 520 positions worth $38.4B, up 12% from $34.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Fred Alger Management's Q4 2020 filing shows 61 new, 186 increased, 165 reduced and 55 closed positions. Its largest new stake was RBC Bearings: 850,381 shares worth $152M. The largest sale was Alibaba, an estimated $530M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fred Alger Management's largest Q4 2020 buy was RBC Bearings: 850,381 shares worth $152M.
- Fred Alger Management added most to CME Group in Q4 2020, an estimated $202M increase.
- Fred Alger Management's biggest Q4 2020 reduction was Alibaba, cutting an estimated $530M.
- Fred Alger Management fully exited Alteryx Inc in Q4 2020, selling an estimated $63.6M.
- Fred Alger Management's ten largest holdings make up 29% of its $38.4B portfolio in Q4 2020.
- Fred Alger Management opened 61 new positions and closed 55 in Q4 2020.
- Fred Alger Management's portfolio value rose 12% quarter-over-quarter to $38.4B.
Based on Fred Alger Management's 13F filing for Q4 2020, filed 16 Feb 2021.